ORIGINAL ARTICLE

1. Pathological significance of abnormal recepteur d’origine nantais and programmed death ligand 1 expression in colorectal cancer
2. Decreased expression of the long non-coding RNA HOXD-AS2 promotes gastric cancer progression by targeting HOXD8 and activating PI3K/Akt signaling pathway
3. Programmed death 1, ligand 1 and 2 correlated genes and their association with mutation, immune infiltration and clinical outcomes of hepatocellular carcinoma
4. LncRNA C9orf139 can regulate the growth of pancreatic cancer by mediating the miR-663a/Sox12 axis
5. Cancer-related microangiopathic hemolytic anemia in patients with advanced gastric cancer: A retrospective single-center analysis
6. Influence of primary tumor location and resection on survival in metastatic colorectal cancer
7. Highly accurate colorectal cancer prediction model based on Raman spectroscopy using patient serum
8. Subtotal gastrectomy combined with chemotherapy: An effective therapy for patients with circumscribed Borrmann type IV gastric cancer
9. Diagnostic value of novel retroflexion colonoscopy in the right colon: A randomized controlled trial

META-ANALYSIS

1. Efficacy and safety of anti-PD-1/anti-PD-L1 antibody therapy in treatment of advanced gastric cancer or gastroesophageal junction cancer: A meta-analysis

CASE REPORT

1. Inferior mesenteric arteriovenous fistula during treatment with bevacizumab in colorectal cancer patient: A case report
2. Cutaneous metastases of pancreatic carcinoma to the labia majora:A case report and review of literature